Cara Therapeutics Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Cara Therapeutics (CARA) Tops Q3 EPS by 8c
November 10, 2015 7:21 AM ESTCara Therapeutics (NASDAQ: CARA) reported Q3 EPS of ($0.19), $0.08 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.77 million.
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.
... More